130-year-old Kodak revamped its finances with a $1B pension reversion, slashing debt to $200M and adding $300M cash, now using its chemical roots to expand beyond film into pharmaceuticals.
Watch FOX Business Rundown: Season 2, Episode 89 - FOX Business: Kodak’s New Focus … A Sharp Turn From Film to Pharma | FOX One